June 15, 2026 · Gynecologic oncology · DOI: 10.1016/j.ygyno.2026.06.009

Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes

Listen to this summary

The authors aimed to evaluate the impact of a structured multimodal prehabilitation program during neoadjuvant chemotherapy (NACT) on chemotherapy delivery, treatment tolerability, and surgical candidacy in patients with advanced-stage ovarian cancer. Their findings indicate that prehabilitation is associated with improved relative dose intensity of chemotherapy and a lower failure rate to proceed to interval debulking surgery, particularly in patients aged 70 and older. These results suggest that prehabilitation may enhance treatment adherence and outcomes in advanced ovarian cancer.

Riham Suleiman, Shilpa Mokshagundam, Matthew S Block, Andrea E Wahner Hendrickson, Kelly H Bruce, William A Cliby, Carrie L Langstraat, S John Weroha, Siddhartha Yadav, Amanika Kumar

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play